Nano Healthcare Technology Market

Nano Healthcare Technology Market Outlook (2023 to 2033)

The global nano healthcare technology market is valued at US$ 7.05 billion in 2023 and is forecasted to secure a revenue of US$ 22.9 billion by the end of 2033. This new Fact.MR market survey projects global demand for nano healthcare technology to rise at a phenomenal 12.5% CAGR over the next ten years.

Focus on healthcare has increased exponentially in recent years, owing to the high prevalence of chronic and infectious diseases around the world. Increasing investments in medical research have provided a new view into the applications of nanotechnology in healthcare, which is expected to boost market growth in the future.

Supportive government initiatives to promote healthcare infrastructure development and advancements in healthcare nanotechnology are also expected to benefit sales of nanotechnology devices over the next ten years. Expanding senescent population, increasing use of nanosensors in diagnostics and treatment, and rising spending on research and development of novel drug delivery systems are also slated to favour nano healthcare technology market development going forward.

On the flip side, lack of awareness regarding nanomedicines and the high costs associated with the use of nanotechnology healthcare devices are anticipated influentially restrain nano healthcare technology demand across the forecast period. The presence of stringent mandates for product approval by regulatory authorities and the lack of skilled professionals to operate nanotechnology devices in the medical field are expected to be major challenges for nano healthcare technology providers in the future.

Increasing incidence of cancer is fuelling demand for novel treatment methods and this is where nanotechnology is expected to exhibit immense growth potential. Injectable nanomedicines and nanorobotics are anticipated to witness an increase in use in cancer treatment applications over the next ten years. New companies can target the use of nanoparticles for cancer treatment to create a space for themselves in the global marketplace.

• Nanobiotix, a biotechnology company based in France, is developing NanoXray products that pile up on cancer cells owing to their surface coating and size. The company has also previously launched Curadigm, a platform that improves the bioavailability of nanomedicines by reducing toxicity in the spleen and liver.

Report Attributes	Details
Nano Healthcare Technology Market Size (2023)	US$ 7.05 Billion
Forecasted Market Value (2033F)	US$ 22.9 Billion
Global Market Growth Rate (2023 to 2033)	12.5% CAGR
Leading Regional Market (2023)	North America
Key Companies Profiled	Stryker Corporation Ferro Corporation Smith & Nephew Inc. GE Global Research Abbott Laboratories Affymetrix Inc. 3M Company St. Jude Medical Inc. AstraZeneca PLC Merck KgaA PerkinElmer Inc. Thermofisher Scientific Inc.

How are Start-ups Reinventing Healthcare through Nanotechnology?

“New Companies Integrating AI & Wearable Technology with Nanotech”

Aspiring nano healthcare technology providers are focusing on the development and launch of innovative healthcare products to increase their sales potential and gain a competitive advantage over other market players.

• Nanowear, a start-up based in the United States, develops cloth-based nanosensors, which are placed in undergarments to monitor and measure stroke volume and cardiac output. The nanosensors developed by this company are already approved by the United States Food and Drug Administration (FDA). These nanosensors could change the future of remote patient monitoring in the healthcare industry over the coming years.

New nano healthcare technology companies are also expected to focus on raising new capital to fund their research and business expansion efforts.

• In March 2022, Causeway Sensors, a nanotechnology-focused company based in the United Kingdom, announced that it had raised around US$ 1.84 million in investment to speed up its commercialization efforts for its patented nanotechnology. The company’s patented technology enables pathogen detection, which opens up new opportunities for nanotechnology in fatal disease detection.
• DendroPharm GmbH, a German company, is focusing on the use of nanotechnology in drug delivery and has developed nanocarriers called DendroSol, which help drugs penetrate the outermost layer of skin. This type of drug delivery system allows the use of a higher quantity of drugs in the affected area more effectively.

An exhaustive and comprehensive analysis of how new developments by start-ups are affecting trends such as local supply, product standards, safety regulations, opportunities, and other aspects has been detailed in this latest nano healthcare technology market research survey by Fact.MR, a market research and competitive intelligence provider.

Country-wise Insights

How Will Nano Healthcare Technology Demand Fare in the United States?

“Rapid Adoption of Advanced Nanotechnology in Healthcare”

The presence of advanced healthcare infrastructure and rapid adoption of novel healthcare technologies are expected to primarily boost demand for nano healthcare technology in the United States over the coming years. Surging spending on medical research and development, supportive government initiatives, and an increasing number of grants being offered are other aspects that could alter sales of nanotechnology devices in healthcare through 2033.

• In July 2022, George Mason University announced that it had received a US$ 3.75 million grant from a state-funded initiative administered by the Virginia Department of Housing and Community Development called GO Virginia. The University had plans to establish a new program named ‘Nano-IMAGINE’ to train the high-tech workforce for the evolving nanotechnology and nanofabrication industry in Virginia.

Increasing prevalence of chronic diseases and rising demand for advanced treatment procedures are also expected to benefit nano healthcare technology market growth in the country across the forecast period.

Which Asian Countries are Leading Nanotechnology Research?

“Japan and South Korea Prime Markets in Asia Pacific”

Japan and South Korea are anticipated to emerge as the most lucrative markets for nanotechnology in the Asia Pacific region owing to high spending on nanotechnology research and notable advancements in nanotech. Supportive government initiatives and a high focus on developing healthcare infrastructure are also expected to promote the adoption of nanotechnology in healthcare applications over the next ten years.

• Researchers at the KAIST (Korea Advanced Institute of Science and Technology), in August 2022, created an electronic tattoo ink that is created from liquid metal. The ink also uses carbon nanotubes as bioelectrodes. When the ink is connected to any biosensor or electrocardiogram (ECG) device, it can monitor and display the vital signs of the patient.

The expertise of Japanese and Korean companies in semiconductor and electronics technologies is also expected to accelerate the development and use of nanotechnology in the healthcare industry going forward.

How Will Demand for Nano Healthcare Technology Fare in Europe?

“Increasing Healthcare Expenditure Offering Moneymaking Opportunities”

Increasing burden of chronic diseases and the rising geriatric population have resulted in high spending on healthcare infrastructure development in several European countries and this is expected to uplift nano healthcare technology demand over the coming years. Supportive government funding to advance healthcare technology and nanotechnology research is also expected to fuel market growth in the European region through 2033.

• In February 2021, the European Commission announced the launch of Horizon Europe, which is the 9th European Framework Programme funding research and innovation with a spending budget of around US$ 103.3 billion from 2021 to 2027. This also includes a specially allocated budget for nanomaterials and nanotechnology.

Surging prevalence of cancer and the growing popularity of personalized medicine are also anticipated to boost the demand for nano healthcare technology in European countries over the coming years. Germany, France, and the United Kingdom are projected to emerge as prime markets in this region going forward.

Category-wise Insights

Which Products Account for a Commanding Market Share?

“Active Implantable Device Sales to Dominate Global Landscape”

Based on product, the nano healthcare technology market is segmented into biochips, implantable materials, medical textiles & wound dressings, active implantable devices, and others.

Active implantable devices are anticipated to account for a significant share of the global marketplace throughout the forecast period. The surging use of active implantable devices in cases of cardiovascular and neurological disorders is expected to be a prime factor adding up to the market share of implantable devices.

Favorable reimbursement policies for implantable devices are also expected to contribute to their rising sales in the future. The increasing popularity of personalized medicines and targeted medicines around the world is estimated to augment the demand for biochips over the next ten years. Rapid advancement in the development of advanced biochips is also expected to bolster shipments of biochips through 2033.

• In January 2022, researchers from the Universidad Politécnica de Madrid (UPM), the Universidad Carlos III de Madrid (UC3M), and other institutions designed a new biochip that simplifies the manufacturing process of in-vitro skin in laboratories.

Competitive Landscape

Prime nano healthcare technology companies are focusing on launching new products that allow them to expand their business potential and compete with established market players.

• In January 2023, ENTOD Pharmaceuticals, a pharmaceutical organization based in India, announced the launch of a new nanotechnology-based ocular aesthetic range in the country. The new range of products is focused on enhancing eye aesthetics and improving eye comfort, which was the brainchild of ENTOD Beauty London and developed by ENTOD Pharmaceuticals.
• In March 2022, Zentek Ltd., a Canadian IP development and commercialization organization that is focused on advancing nanotechnology-based healthcare solutions, stated that it was focusing on the commercialization of ZenGUARD, which had depicted 99% activity against microbes.

More detailed insights about new developments by leading nano healthcare technology providers and how they affect the global competitive landscape have been discussed in detail in this latest Fact.MR research analysis.

Key Segments of Nano Healthcare Technology Industry Research

• By Product :

  • Biochips
  • Implantable Materials
  • Medical Textiles & Wound Dressings
  • Active Implantable Devices
  • Others

• By Application :

  • Therapeutic Applications
  • Diagnostic Applications
  • Research Applications

• By Region :

  • North America
  • Latin America
  • Europe
  • APAC
  • MEA